Stuart Smith (@sjsmithstuart) 's Twitter Profile
Stuart Smith

@sjsmithstuart

ID: 3094911129

calendar_today18-03-2015 16:58:32

232 Tweet

154 Followers

340 Following

Tessa Jowell Brain Cancer Mission (@tjbcmission) 's Twitter Profile Photo

We are proud to share our new report setting out the future of genomic testing for patients with a brain tumour. The report highlights the inequity of access to key tests, challenges in the pathway and lays out clear recommendations. Click to read āž”ļø bit.ly/3Xlc3e2

We are proud to share our new report setting out the future of genomic testing for patients with a brain tumour.  The report highlights the inequity of access to key tests, challenges in the pathway and lays out clear recommendations. Click to read āž”ļø bit.ly/3Xlc3e2
Matt Loose (@mattloose) 's Twitter Profile Photo

Introducing ROBIN. Rapid nanopOre Brain intraoperatIve classificatioN. ROBIN builds on work by many groups and shows how we could reduce turnaround time for full molecular classification of CNS tumours in NHS clinical settings from weeks to hours. medrxiv.org/content/10.110…

Introducing ROBIN. Rapid nanopOre Brain intraoperatIve classificatioN. ROBIN builds on work by many groups and shows how we could reduce turnaround time for full molecular classification of CNS tumours in NHS clinical settings from weeks to hours. medrxiv.org/content/10.110…
Matt Loose (@mattloose) 's Twitter Profile Photo

It's very good to see this report out and the transformations that are needed. The report references future technologies being trialled in Nottingham University Hospitals - we now have a preprint out that describes this work in more detail - medrxiv.org/content/10.110…

Matt Loose (@mattloose) 's Twitter Profile Photo

Great to see this review out from @simonpdeacon Stuart Smith and Simon Paine from Nottingham University Hospitals on Oxford Nanopore potential in diagnostic pathology. authors.elsevier.com/a/1jumt6FKYG3M… This link is free for 50 days apparently!

Maryland Neurosurgery (@umdneurosurgery) 's Twitter Profile Photo

Congratulations to PGY5 Riccardo Serra on his new paper on local Olaparib use in Glioblastoma. Great work with collaborators at the Hunterian Lab and University of Nottingham. Riccardo Serra Ruman Rahman Johns Hopkins Neurosurgery nature.com/articles/s4141…

Congratulations to PGY5 Riccardo Serra on his new paper on local Olaparib use in Glioblastoma. Great work with collaborators at the Hunterian Lab and University of Nottingham. <a href="/RiccardoSerra20/">Riccardo Serra</a> <a href="/rumanrahman01/">Ruman Rahman</a> <a href="/HopkinsNsurg/">Johns Hopkins Neurosurgery</a> 

nature.com/articles/s4141…
Stuart Smith (@sjsmithstuart) 's Twitter Profile Photo

Sadly a similar experience already occurs for many brain tumour patients. Radical change needed as the number of patients across all cancers needing these tests increases rapidly

Matt Loose (@mattloose) 's Twitter Profile Photo

Congrats to Stuart Smith and Dr Simon Paine for winning the #NIHAwards Innovation award for work on bringing Oxford Nanopore sequencing into the clinic for rapid brain tumour diagnosis.

Congrats to <a href="/SjsmithStuart/">Stuart Smith</a> and Dr Simon Paine for winning the #NIHAwards Innovation award for work on bringing <a href="/nanopore/">Oxford Nanopore</a> sequencing into the clinic for rapid brain tumour diagnosis.
Piers Morgan (@piersmorgan) 's Twitter Profile Photo

Proud to support #ShineALight for Brain Tumour Awareness Month & ⁦Brain Tumour Research⁩ - one in three of us know someone with a brain tumour (I lost a great mate, Miles, to glioblastoma recently) yet only 1% of the UK’s cancer research spend goes into them. This must change.

Oxford Nanopore (@nanopore) 's Twitter Profile Photo

From weeks to hours. Prof. Matt Loose shares a transformative tool (ROBIN) that uses Oxford Nanopore technology to rapidly and comprehensively classify central nervous system tumours in this webinar. Watch here to discover what’s possible: bit.ly/42FRV9g

From weeks to hours.  

Prof. Matt Loose shares a transformative tool (ROBIN) that uses Oxford Nanopore technology to rapidly and comprehensively classify central nervous system tumours in this webinar. 
Watch here to discover what’s possible: bit.ly/42FRV9g
Oxford Nanopore (@nanopore) 's Twitter Profile Photo

The future is now. In this webinar, Prof. Matt Loose showcases a revolutionary tool, ROBIN, that uses Oxford Nanopore technology for rapid and comprehensive molecular profiling of central nervous system tumours. Watch the webinar here: bit.ly/3REqZSd

The future is now. 

In this webinar, Prof. Matt Loose showcases a revolutionary tool, ROBIN, that uses Oxford Nanopore technology for rapid and comprehensive molecular profiling of central nervous system tumours. 

Watch the webinar here: bit.ly/3REqZSd
The Brain Tumour Charity (@braintumourorg) 's Twitter Profile Photo

An ultra-rapid method of genetically diagnosing brain tumours has been developed, cutting the classification time from 6-8 weeks, to as little as two hours. This could remove uncertainty those face waiting weeks for their diagnosis and prognosis. Read more:bit.ly/43EbUXh

An ultra-rapid method of genetically diagnosing brain tumours has been developed, cutting the classification time from 6-8 weeks, to as little as two hours. This could remove uncertainty those face waiting weeks for their diagnosis and prognosis. Read more:bit.ly/43EbUXh
Less Survivable Cancers Taskforce (@lesssurvivable) 's Twitter Profile Photo

Great news about a new test that reduces diagnosis time for certain types of brain tumour. This highlights the importance of continued research to improve earlier diagnosis and faster detection for the less survivable cancers. bbc.co.uk/news/articles/…

Oxford Nanopore (@nanopore) 's Twitter Profile Photo

Knowledge is power. In the studio, Matt Loose shared insights on rapid CNS profiling — and how one participant told him: ā€œEven if the answer isn’t what you want, it’s better than not knowing at all.ā€

Oxford Nanopore (@nanopore) 's Twitter Profile Photo

In the studio, Matt Loose shares how: ā€œSurgeons were literally knocking, saying I’ve got a patient today. Once people see what’s possible, they start to believe it — and get excited.ā€ when talking about his new CNS tumour profiling method.

Oxford Nanopore (@nanopore) 's Twitter Profile Photo

Why wait weeks for a diagnosis? Danny Miller discusses the future potential of Oxford Nanopore sequencing, and how clinicians could get actionable results within hours—not days or weeks. No need to batch samples. Same-day sequencing, same-day answers. #NanoporeConf

Oxford Nanopore (@nanopore) 's Twitter Profile Photo

A breakthrough moment in brain infections. Faced with a mystery infection, Judith Breuer sequenced a biopsy sample—and identified a pathogen never before linked to brain infections. Find out more. #NanoporeConf

BNOS (@bnosofficial) 's Twitter Profile Photo

Our winner of the Young Investigator Award 2025 is Phoebe McCrorie. Congratulations! Thank you to Karen Noble at Brain Tumour Research for supporting this alongside BNOS. Photo - Karen Noble, Phoebe McCrorie, Susan Short. #BNOS2025

Our winner of the Young Investigator Award 2025 is Phoebe McCrorie. Congratulations! 
Thank you to Karen Noble at Brain Tumour Research for supporting this alongside BNOS. 

Photo - Karen Noble, Phoebe McCrorie, Susan Short. #BNOS2025